pneumococcal disease

Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants
Clinical Trials Arena
Wed, 12/4/24 - 09:59 am
Vaxcyte
clincal trials
VAX-31
vaccines
pneumococcal disease
GSK axes vaccine from $2.1B deal, switching to preclinical successor over 'increased competition'
Fierce Biotech
Thu, 10/31/24 - 09:37 am
GSK
Affinivax
vaccines
pneumococcal disease
In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines
Fierce Pharma
Wed, 10/23/24 - 10:35 pm
Pfizer
Merck
pneumococcal disease
CDC
vaccines
Vaxcyte's 'stunning' 31-valent pneumococcal vaccine win against Pfizer's Prevnar 20 has analysts thinking big
Fierce Biotech
Tue, 09/3/24 - 11:10 am
Vaxcyte
clinical trials
vaccines
pneumococcal disease
VAX-31
Merck's Capvaxive gears up to challenge Pfizer's dominant Prevnar with CDC panel backing
Fierce Pharma
Sun, 06/30/24 - 09:59 pm
Merck
Pfizer
vaccines
pneumococcal disease
Prevnar
Capvaxive
This Recent FDA Approval Is Bad News for Pfizer
Motley Fool
Thu, 06/27/24 - 11:31 am
Pfizer
Merck
FDA
vaccines
pneumococcal disease
Merck gets shot in the arm with FDA approval for first pneumococcal vaccine designed for adults
Fierce Pharma
Mon, 06/17/24 - 10:37 pm
Merck
vaccines
FDA
pneumococcal disease
Capvaxive
V116
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
Fierce Biotech
Mon, 04/29/24 - 10:50 pm
Merck
vaccines
V116
pneumococcal disease
Pfizer
FDA accepts Merck’s pneumococcal vaccine BLA for priority review
Pharmaceutical Technology
Wed, 12/20/23 - 09:34 am
Merck
vaccines
FDA
pneumococcal disease
V116
Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators
Fierce Pharma
Tue, 11/28/23 - 11:52 am
Merck
Pfizer
vaccines
clinical trials
pneumococcal disease
V116
Prevnar 20
Pfizer takes scalpel to early-phase pipeline, slicing off RSV, eczema, sickle cell and cancer programs
Fierce Biotech
Tue, 08/1/23 - 10:09 am
Pfizer
RSV
sickle cell disease
pneumococcal disease
cancer
Merck’s next-gen pneumococcal vaccine strides forward after two phase 3 wins
Fierce Biotech
Thu, 07/27/23 - 11:38 am
Merck
pneumococcal disease
vaccines
clinical trials
V116
Pfizer wins FDA nod for Prevnar 20 pneumonia vaccine in children
Seeking Alpha
Thu, 04/27/23 - 10:56 pm
Pfizer
vaccines
FDA
Prevnar 20
pneumococcal disease
pediatric
Vaxcyte Up on Pneumococcal Conjugate Vaccine Data
Zacks.com
Wed, 04/19/23 - 10:23 am
Vaxcyte
vaccines
clinical trials
pneumococcal disease
VAX-24
Vaxcyte strengthens case for experimental pneumococcal vaccine
BioPharma Dive
Tue, 04/18/23 - 10:06 am
Vaxcyte
vaccines
clinical trials
pneumococcal disease
After going head-to-head with Prevnar 20, Vaxcyte's 24-valent pneumococcal shot will seek a pivotal win
Endpoints
Mon, 10/24/22 - 11:19 am
Vaxcyte
vaccines
VAX-24
pneumococcal disease
Pfizer
Prevnar 20
clinical trials
Pfizer's 20-valent pneumococcal vaccine hits goal in infant trial, teeing up 2022 approval filing
Fierce Biotech
Fri, 08/12/22 - 10:16 am
Pfizer
vaccines
Prevnar 20
FDA
infants
clinical trials
pneumococcal disease
Big pharma’s key third-quarter data
EP Vantage
Tue, 06/28/22 - 10:37 am
GSK
Roche
Pfizer
JNJ
AstraZeneca
Novo Nordisk vaccines
clinical trials
pneumococcal disease
crovalimab
rheumatoid arthritis
Merck outflanks Pfizer's 20-valent shot with pneumococcal vaccine approval for kids
Endpoints
Wed, 06/22/22 - 10:57 am
Merck
FDA
vaccines
pneumococcal disease
Vaxneuvance
Pfizer
Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development
BioSpace
Tue, 06/21/22 - 12:02 pm
Merck
Emergent BioSolutions
Affinivax
Ocugen
vaccines
chikungunya virus
pneumococcal disease
COVID-19

Pages